Transcend Medical Raises $35 Million Series B Round Towards Development Of Novel Glaucoma Treatment

Transcend Medical, Inc., an ophthalmic device company dedicated to delivering breakthrough advances in the treatment of glaucoma, announced today that it has closed a $35 million Series B round and is continuing the rapid development of its Transcend CyPass(TM) System, a novel proprietary system for the minimally-invasive treatment of glaucoma.
Polygraphy

California's Struggle With Insurance Exchanges Offers Lesson For National Reform

California"s experience with insurance exchanges could prove a valuable lesson for the nation"s flirtation with such pools for covering large numbers of people, The Wall Street Journal reports.

News of the day

Personal Exposure Monitors Show Pharmacy Workers Inhale Drugs When Using Air Pressure-Activated Dispensing Machines

AlburtyLab released a report on its comprehensive evaluation of health risks for workers in pharmacies using air pressure-activated drug dispensing machines. The study tested pharmacy workers wearing personal exposure monitors (PEMs) while using the two leading types of air pressure-activated dispensing technologies - the McKesson/Parata Max and the McKesson/Parata RDS. This is the third major study conducted by AlburtyLab examining the issues relating to pharmacy worker exposure.

Your message:
Your name/organization:
Your E-mail:
Enter today\\'s date, 2 digits (spam protection):

Transcend Medical Raises $35 Million Series B Round Towards Development Of Novel Glaucoma Treatment

California's Struggle With Insurance Exchanges Offers Lesson For National Reform

Personal Exposure Monitors Show Pharmacy Workers Inhale Drugs When Using Air Pressure-Activated Dispensing Machines

Send email